Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICR suckling Swiss mice

Journal of Parasitology

Volumn 84, Issue 4, 1998, Pages 851-856

  Blagburn, Byron L ^a   Drain, Kathryn L ^a   Land, Tracey M ^a   Moore, P Hutton ^a   Kinard, Rachel G ^a   Lindsay, David S ^a   Kumar, Arvind ^a,b   Shi, Junxing ^a,b   Boykin, David W ^a,b   Tidwell, Richard R ^a,c  

^a AUBURN UNIVERSITY   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; DIMETHYL SULFOXIDE; FURAN DERIVATIVE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; INOCULATION; INTESTINE PARASITE; MOUSE; NEWBORN; NONHUMAN; OOCYST; ORAL DRUG ADMINISTRATION; PARASITE DEVELOPMENT; SUCKLING;

ANIMALS; ANIMALS, SUCKLING; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODELS, ANIMAL; FURANS; MICE; MICE, INBRED ICR;

EID: 0346666412     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.2307/3284603     Document Type: Article

References (27)

1. BELL, C. A., C. C. DYKSTRA, N. A. NAIMAN, M. CORY, T. A. FAIRLEY, AND R. R. TIDWELL. 1993. Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of anti-giardial activity with DNA binding affinity and giardial topoisomerase II inhibition. Antimicrobial Agents and Chemotherapy 37: 2668-2673.
2. BLAGBURN, B. L., AND R. SOAVE. 1997. Prophylaxis and chemotherapy. In Cryptosporidium and cryptosporidiosis, R. Fayer (ed.). CRC Press, Boca Raton, Florida, p. 111-128.
3. _, C. A. SUNDERMANN, D. S. LINDSAY, J. E. HALL, AND R. R. TIDWELL. 1991. Inhibition of Cryptosporidium parvum in Neonatal Hsd : (ICR) BR Swiss mice by polyether ionophores and aromatic amidines. Antimicrobial Agents and Chemotherapy 35: 1520-1523.
4. BOYKIN, D. W., A. KUMAR, J. SPYCHALA, M ZHOU, R. J. LOMBARDY, W. D. WILSON, C. C. DYKSTRA, S. K. JONES, J. E. HALL, R. R. TIDWELL, C. LAUGHTON, AND C. M. NEIDLE. 1995. Dicationic diarylfurans as anti-Pneumocystis carinii agents. Journal of Medicinal Chemistry 38: 912-916.
5. _,_, G. XIAO, W. D. WILSON, B. K. BENDER, D. R. MCCURDY, J. E. HALL, AND R. R. TIDWELL. 1998. 2,5-Bis-[4(N-alkylamidino)phenyl]furans as Pneumocystis carinii agents. Journal of Medicinal Chemistry 41: 124-129.
6. CASEMORE, D. P., S. E. WRIGHT, AND R. L. COOP. 1997. Cryptosporidiosis - Human and animal epidemiology. In Cryptosporidium and cryptosporidiosis, R. Fayer (ed.). CRC Press. Boca Raton, Florida, p. 65-92.
7. DAS, B. P., AND D. W. BOYKIN. 1977. Synthesis and antiprotozoal activity of 2,5-bis-(4-guanylphenyl)furans. Journal of Medicinal Chemistry 20: 531-536.
8. DONKOR, I. O., S. K. JONES, AND R. R. TIDWELL. 1993. Pentamidine congeners 1: Synthesis of cis-and trans-butamidine analogues as anti-Pneumocystis carinii pneumonia agents. Antimicrobial Agents and Chemotherapy 38: 1890-1898.
9. DYKSTRA, C. C., D. R. MCCLERNON, L. P. ELWELL, AND R. R. TIDWELL. 1994. Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells. Antimicrobial Agents and Chemotherapy 38: 1890-1898.
10. FAYER, R., AND W. ELLIS. 1993. Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. Journal of Parasitology 79: 553-558.
11. _, C. A. SPEER, AND J. P. DUBEY. 1997. General biology of Cryptosporidium. In Cryptosporidium and cryptosporidiosis. R. Payer (ed.). CRC Press, Boca Raton, Florida, p. 1-41.
12. FINCH, G. R., C. W. DANIELS, E. K. BLACK, F. W. SCHAEFER III. AND M. BELOSEVIC. 1993. Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice. Applied and Environmental Microbiology 59: 3661-3665.
13. FLANAGAN, T., R. MARSHALL, D. REDMAN, C. K. HETZEL, AND B. R. L. UNGAR. 1991. In vitro screening of therapeutic agents against Cryptosporidium: Hyperimmune cow colostrum is highly inhibitory. Journal of Protozoology 38: 225S-227S.
14. HILDEBRANDT, E., D. W. BOYKIN, A. KUMAR, R. R. TIDWELL, AND C. C. DYKSTRA. 1998. Identification and characterization of an endo/exonuclease in Pneumocystis carinii that is inhibited by dicationic diarylfurans with efficacy against Pneumocyslis pneumonia. Journal of Eukaryotic Microbiology 45: 112-121.
15. JONES, S. K., J. E. HALL, M. A. ALLEN, S. D. MORRISON, K. A. OHEMENG, V. V. REDDY, J. D. GERATZ, AND R. R. TIDWELL. 1990. Novel pentamidine analogues in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy 34: 1026-1030.
16. LEMETEIL, D., F. ROUSSEL, L. FAVENNEC, J. J. BALLET, AND P. BRASSEUR. 1993. Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. Journal of Infectious Diseases 167: 766-768.
17. MEAD, J. R., Y. XIANGDONG, J. E. PHARR, Y. BELENKAYA, M. J. ARROWOOD, M. T. FALLON, AND R. F. SCHINAZI. 1995. Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis. Antimicrobial Agents and Chemotherapy 39: 854-858.
18. O'DONOGHUE, P. J. 1995. Cryptosporidium and cryptosporidiosis in man and animals. International Journal of Parasitology 25: 139-195.
19. PATRICK. D. A., D. W. BOYKIN, W. D. WILSON, B. C. BENDER, J. E. HALL, C. C. DYKSTRA, K. A. OHEMENG, AND R. R. TIDWELL. 1997. Anti-Pneumocystis carinii pneumonia activity of dicationic carbazoles. European Journal of Medicinal Chemistry 32: 781-793.
20. REHG, J. 1994. New potential therapies for cryptosporidiosis; an analysis of variables affecting drug efficacy. Folia Parasitologica 41: 23-26.
21. _. 1996. Effect of diethyldithiocarbamate on Cryptosporidium parvum infections in immunosuppressed rats. Journal of Parasitology 82: 158-162.
22. ROSE, J. B., J. T. LISLE, AND M. LECHEVALLIER. 1997. Waterborne cryptosporidiosis: Incidence, outbreaks, and treatment strategies. In Cryptosporidium and cryptosporidiosis, R. Fayer (ed.). CRC Press, Boca Raton, Florida, p. 93-109.
23. SMITH, P. D., H. LANE, V. J. GILL, J. F. MANISCHEWITZ, G. V. QUINNAN, A. S. FAUCI, AND H. MASUR. 1988. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Annals of Internal Medicine 108: 328-333.
24. TIDWELL, R. R., S. K. JONES, J. D. GERATZ, K. A. OHEMENG, C. A. BELL, B. J. BERGER, AND J. E. HALL. 1990. Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia. Annals of the New York Academy of Sciences 616: 421-441.
25. _, S. G. KILGORE, J. D. GERATZ, K. A. OHEMENG, M. CORY, AND J. E. HALL. 1990. Analogues of 1,5-bis (4-amidophenoxy) pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. Journal of Medicinal Chemistry 33: 1252-1257.
26. UPTON, S. J., AND H. H. GILLOCK. 1996. Infection dynamics of Cryptosporidium parvum in ICR outbred suckling mice. Folia Parasitologica 43: 101-106.
27. WILSON, W. D., L. RATMEYER, M. ZHAO, L. STREKOWSKI, AND D. W. BOYKIN. 1993. The search for structure-specific nucleic acid-interactive drugs. Effects of compound structure on RNA versus DNA interaction strength. Biochemistry 32: 4098-4104.